Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
03/14/2007 | EP1762617A1 Method for manufacturing recombinant polyclonal proteins |
03/14/2007 | EP1762610A1 Truncated dance, dance complex and method of using these |
03/14/2007 | EP1762575A1 Identification of tumor-associated antigens for diagnosis and therapy |
03/14/2007 | EP1761822A2 A dynamic fluid control system for immersion lithography |
03/14/2007 | EP1761778A2 Method for determining aggrecanase activities |
03/14/2007 | EP1761566A1 Humanized anti-tag-72 monoclonal antibodies |
03/14/2007 | EP1761565A2 Compositions and methods for treating inflammatory disorders |
03/14/2007 | EP1761564A1 Method and device for detecting feline immunodeficiency virus |
03/14/2007 | EP1761563A2 HUMANIZED Fc gamma RIIB SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
03/14/2007 | EP1761562A2 Conformation specific antibodies |
03/14/2007 | EP1761561A2 Antibody specificity transfer using minimal essential binding determinants |
03/14/2007 | EP1513878B1 Compositions and methods for apo-b48 and apo-b100 assay |
03/14/2007 | EP1386161B1 Screening method using pim1-kinase or pim3-kinase |
03/14/2007 | EP1325956B1 Plant lesion formation suppressing gene, spl7 and use theriof |
03/14/2007 | EP1305434B1 A human disintegrin protein |
03/14/2007 | EP1254180B1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
03/14/2007 | EP1226169B1 Molecular structure of rhd negative locus |
03/14/2007 | EP1098979B1 Antibody with improved producibility |
03/14/2007 | EP1007697B1 Production of proteins in eggs |
03/14/2007 | EP0966302B1 Methods of therapeutic administration of anti-cd40l compounds |
03/14/2007 | EP0912610B1 A novel galanin receptor |
03/14/2007 | EP0698089B1 Nucleic acid encoding amp-activated protein kinase |
03/14/2007 | CN1930474A Method of detecting allergen |
03/14/2007 | CN1930461A Methods for diagnosis and pronosis of cancers of epithelial origin |
03/14/2007 | CN1930304A Asymmetrically branched polymer conjugates and microarray assays |
03/14/2007 | CN1930288A Cells of which genome is modified |
03/14/2007 | CN1930188A Estrogen receptors and methods of use |
03/14/2007 | CN1930187A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
03/14/2007 | CN1930184A Novel TAT complexes, and vaccines comprising them |
03/14/2007 | CN1929862A Use of antagonist anti-CD40 antibodies for treatment of chronic lymphocytic leukemia |
03/14/2007 | CN1927887A Anti-rabies virus recombination immune toxin and preparation process |
03/14/2007 | CN1927886A Preparation method and application of heterogenous resisting gosling blast yolk antibody for preventing and curing gosling blast |
03/14/2007 | CN1927885A Preparation method of heterogenous yolk antibody for resisting gosling blast and viral hepatitis |
03/14/2007 | CN1927884A Preparation method of heterogenous yolk antibody for preventing and curing duck viral hepatitis |
03/14/2007 | CN1927883A 新的细胞因子zalpha11配体 New cytokine zalpha11 Ligand |
03/14/2007 | CN1927397A Extraction method of animal blood plasma immunoglobulin oral administration preparation |
03/14/2007 | CN1927137A Pre-transplant accommodated organs resistant to anti-donor immunity |
03/14/2007 | CN1304574C Recombination human erythropoietin gene suitable for pronucleus expression system and its expression carrier |
03/14/2007 | CN1304568C Novel human complement C1r-like serine proteinase analogue, and its encoding sequence and use |
03/14/2007 | CN1304051C PSGL-1 regulator |
03/14/2007 | CN1303977C Pro-micelle pharmaceutical compositions |
03/13/2007 | US7189841 A degenerate 5' primer that hybridizes to a region of a VH immunoglobulin domain, wherein the primer consists of 15 to 25 nucleotides and is substantially complementary to a nucleotide sequence conserved in any one of the leader or first framework regions; libraries |
03/13/2007 | US7189839 An isolated polynucleotide that encodes a polypeptide comprising an amino acid sequence that represents the extracellular domain, also called a cytokine-binding domain, of a new human soluble class II cytokine receptor designated Zcytor16; antiarthritic and -inflammatory agents; autoimmune diseases |
03/13/2007 | US7189838 PRO9834 nucleic acids |
03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
03/13/2007 | US7189830 Anti-KSA/IL-2 fusion proteins with reduced immunogenicity |
03/13/2007 | US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins |
03/13/2007 | US7189826 Hybridomas cell lines; viricides |
03/13/2007 | US7189825 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents; immunotherapy |
03/13/2007 | US7189824 Monoclonal antibody which recognizes an antigen on the surface of tumor vessel endothelial cells; conjugates with diagnostic, chemotherapeutic agents for diagnosis or treatment of tumors |
03/13/2007 | US7189823 Monoclonal antibody useful in the diagnosis of proliferative disorders of the colon such as colon cancer; ILLFDYFNR is a colon cancer antigen sequence |
03/13/2007 | US7189822 Antibodies to a polypeptide encoded by a nucleic acid underexpressed in stomach and lung tumor |
03/13/2007 | US7189821 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
03/13/2007 | US7189819 Humanized antibodies that recognize beta amyloid peptide |
03/13/2007 | US7189818 Transcriptional regulator |
03/13/2007 | US7189817 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/13/2007 | US7189816 Antibody having a binding structure comprising specified complementarity determining region (CDR) sequences for a target tumor antigen on human gastrointestinal epithelial tumour cells; colon cancer diagnosis or immunotherapy |
03/13/2007 | US7189815 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/13/2007 | US7189814 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/13/2007 | US7189813 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
03/13/2007 | US7189812 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
03/13/2007 | US7189807 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
03/13/2007 | US7189800 Forming vaccines; analyzing hemagglutinin, calibration |
03/13/2007 | US7189703 Treatment and diagnosis of alzheimer's disease |
03/13/2007 | US7189699 Polypeptide which interfers with amyloid formation |
03/13/2007 | US7189698 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
03/13/2007 | US7189582 Compositions and methods for detection of sirolimus |
03/13/2007 | US7189566 Nucleotide sequences coding polypeptide for use in the treatment of bone, arthritic, inflammatory, fertility and atherosclerotic disorders |
03/13/2007 | US7189551 Human RPS6KA6-related gene variant associated with lung cancers |
03/13/2007 | US7189535 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
03/13/2007 | US7189525 Human enzymes of the metalloprotease family |
03/13/2007 | US7189520 Compositions and methods for detecting animal byproduct in feed |
03/13/2007 | US7189517 Goodpasture antigen binding protein |
03/13/2007 | US7189515 Human antibodies as detection reagents |
03/13/2007 | US7189413 Drug delivery of proteins from polymeric blends |
03/13/2007 | US7189398 Amino acid sequence substantially homologous to the amino acid sequence of a fragment of a pyrogenic exotoxin, capable of eliciting protective immunity against toxic shock induced by a pyrogenic exotoxin |
03/13/2007 | US7189397 Screening fir cytotoxic end points; cancerous disease modifying antibodies |
03/13/2007 | US7189396 Delivery system using mAb 3E10 and mutants and/or functional fragments thereof |
03/13/2007 | US7189394 Method for treating inflammation |
03/13/2007 | CA2394609C Conformational and topological protein regulation |
03/13/2007 | CA2311641C Pseudo-type retroviral vectors with modifiable surface capsid proteins |
03/13/2007 | CA2262531C Assessment of cervical cells |
03/13/2007 | CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
03/13/2007 | CA2160922C Hiv immunogenic complexes |
03/13/2007 | CA1341522C Novel granulocyte colony stimulating factor polypeptide derivatives |
03/08/2007 | WO2007027954A2 Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof |
03/08/2007 | WO2007027751A2 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
03/08/2007 | WO2007027748A2 C/clp antagonists and methods of use thereof |
03/08/2007 | WO2007027714A2 Engineered anti-il-23 antibodies |
03/08/2007 | WO2007027713A2 Trail receptor 2 polypeptides and antibodies |
03/08/2007 | WO2007026972A2 Binding protein molecule |
03/08/2007 | WO2007026960A1 Use of mocs3 gene for therapeutic or diagnostic purposes |
03/08/2007 | WO2007026926A1 NOVEL 16S rRNA METHYLASE GENE, PROTEIN PRODUCED FROM THE GENE, AND METHOD FOR DETECTION OF THE GENE OR PROTEIN |
03/08/2007 | WO2007026689A1 Antibody produced using ostrich and method for production thereof |
03/08/2007 | WO2007026661A1 Method for specifically selecting antibody-producing cell |
03/08/2007 | WO2007026516A1 Novel drug delivery system |
03/08/2007 | WO2007026000A2 Human fvii monoclonal antibodies binding the gla domain and use thereof |
03/08/2007 | WO2007025977A2 Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis |
03/08/2007 | WO2007025781A2 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |